Abdulla Fouad for Medical Supplies & Services Company (AFMS) achieved significant recognition at the QIAGEN 2023 Summit, receiving two prestigious Best Performance Awards. The first award celebrates AFMS's remarkable success with QIAstat products, which offer highly accurate syndromic testing for infectious diseases, focusing on Respiratory Infection, Gastrointestinal Infection, and Meningitis. These cutting-edge solutions provide patients and physicians with reliable results, elevating healthcare standards and patient care.
The second award acknowledges AFMS's instrumental role in the fight against TB, where the company's dedication to providing the best solution for detecting latent TB, QuantiFERON Gold, has made a lasting impact. Through this innovative technology, healthcare providers can effectively identify and manage latent TB cases, contributing to better patient outcomes and improved public health.
The accolades received by AFMS exemplify the company's commitment to excellence in delivering state-of-the-art healthcare solutions to the Kingdom of Saudi Arabia. The achievements are a testament to the dedication and expertise of the AFMS team, whose efforts have been recognized by QIAGEN, a global leader in the field.
AFMS expresses deep gratitude to QIAGEN for the recognition, and reaffirms its unwavering commitment to advancing healthcare and continuously improving patient care in the region. Through strategic partnerships and a dedication to providing top-quality medical supplies and services, AFMS continues to make significant contributions to the transformation of healthcare in the Kingdom of Saudi Arabia.
